Lysis of fresh murine mammary tumor cells by syngeneic natural killer cells and lymphokine-activated killer cells
- 1 November 1987
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 25 (3) , 161-168
- https://doi.org/10.1007/bf00199142
Abstract
We have compared the ability of natural killer (NK) cells from two substrains of C3H mice that differ with respect to their susceptibility to the development of mammary adenocarcinomas to lyse fresh syngeneic mammary tumor cells. Single cell suspensions of mammary tumors from retired breeder females were used as targets in 22-h 51Cr-release cytotoxicity assays with syngeneic NK cells. Tumor cell suspensions were prepared by enzymatic digestion of finely minced tissue followed by centrifugation through a discontinuous Percoll gradient. Effector cells were prepared by passing spleen cells over nylon wool followed by centrifugation through Percoll fraction 7. Syngeneic NK cells had significant levels of lysis against 5/8 tumors studied. NK cells from low risk animals (C3Heb/FeJ) consistently demonstrated greater cytotoxicity against tumor cell preparations than did effectors from the high tumor substrain (C3H/OuJ). Study of cytocentrifuge preparations stained with Wright-Giemsa revealed that the two substrains were identical with respect to the number of azurophilic granules present in the cytoplasm of their NK cells. We have also shown that lymphokine-activated killer (LAK) cells can be generated from splenocytes in C3H mice. While LAK cells from both substrains were capable of lysing fresh syngeneic mammary tumor cells in vitro, LAK cells from the animals at high risk for the formation of mammary adenocarcinomas had greater cytotoxicity against tumor cell suspensions than LAK cells from the low tumor substrain.Keywords
This publication has 52 references indexed in Scilit:
- Human lymphokine-activated killer cells (LAK cells) as a potential immunotherapeutic modalityBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1986
- Generation of lymphokine-activated killer (LAK) cells from tumor-infiltrating lymphocytesCellular Immunology, 1986
- Decreased natural cytotoxicity in mice with high incidence of mammary adenocarcinomaClinical Immunology and Immunopathology, 1986
- Modulation of stimulatory effects of poly(I:C) on natural cytotoxicity by anti-interferonCellular Immunology, 1984
- Natural Killer Cells: Their Roles in Defenses Against DiseaseScience, 1981
- Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphcoytes.The Journal of Experimental Medicine, 1980
- Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient miceNature, 1980
- Role of NK cells in tumour growth and metastasis in beige miceNature, 1980
- Positive correlation between in vitro NK activity and in vivo resistance towards AKR lymphoma cellsInternational Journal of Cancer, 1980
- Reduced Incidence of Spontaneous Mammary Tumors in C3H/He Mice After Treatment with Polyadenylate-PolyuridylateScience, 1975